Zensar Technologies is currently trading at Rs. 449.00, up by 6.00 points or 1.35% from its previous closing of Rs. 443.00 on the BSE.
The scrip opened at Rs. 446.00 and has touched a high and low of Rs. 455.00 and Rs. 446.00 respectively. So far 6922 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 473.55 on 23-Jul-2014 and a 52 week low of Rs. 180.90 on 25-Sep-2013.
Last one week high and low of the scrip stood at Rs. 462.00 and Rs. 409.35 respectively. The current market cap of the company is Rs. 1974.60 crore.
The promoters holding in the company stood at 48.18% while Institutions and Non-Institutions held 12.66% and 39.16% respectively.
Zensar Technologies, a leading software services and infrastructure provider has won new orders in Germany and Europe in July. The company has also opened a new office in Switzerland with other global office in Kenya this year.
The company has dedicated sales teams in the region focused on the Benelux and DACH countries, with special focus on the small and medium-sized enterprises in German-speaking countries. It has offices in Slough in UK, Veenendal and Amsterdam in Netherlands, Munich in Germany, Vienna in Austria and Geneva in Switzerland.
In the first quarter of the current fiscal, Zensar Europe has shown a year on year growth of 47.4% in USD terms. The Application Services business of the company posted strong growth of 4.6% in USD terms on a sequential quarter basis with the key markets of US and Europe growing 7.1% in USD terms, on a sequential quarter basis. With ail services businesses on a good growth track and a sign of economic health in all key markets, the software major is poised for a period of strong growth.
Zensar Technologies is among the top 20 software services providers from India. Zensar is the world's first enterprise-wide SEI CMM Level 5 Company and was also later certified as a CMMI Level 5 Company with industry expertise that spans Retail, Manufacturing, Banking, Insurance, Utilities, Healthcare and Life Sciences.